A detailed history of Prudential Financial Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 31,261 shares of HRMY stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,261
Previous 34,071 8.25%
Holding current value
$1.03 Million
Previous $1.03 Million 21.52%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.0 - $39.95 $84,300 - $112,259
-2,810 Reduced 8.25%
31,261 $1.25 Million
Q2 2024

Aug 13, 2024

SELL
$28.81 - $33.01 $86,430 - $99,030
-3,000 Reduced 8.09%
34,071 $1.03 Million
Q1 2024

May 14, 2024

SELL
$29.93 - $35.06 $13,169 - $15,426
-440 Reduced 1.17%
37,071 $1.24 Million
Q4 2023

Feb 13, 2024

SELL
$19.2 - $33.78 $561,235 - $987,423
-29,231 Reduced 43.8%
37,511 $1.21 Million
Q3 2023

Nov 13, 2023

SELL
$31.89 - $39.03 $94,011 - $115,060
-2,948 Reduced 4.23%
66,742 $2.19 Million
Q2 2023

Aug 11, 2023

BUY
$30.5 - $37.4 $396,835 - $486,611
13,011 Added 22.96%
69,690 $2.45 Million
Q1 2023

May 12, 2023

SELL
$30.8 - $53.92 $361,746 - $633,290
-11,745 Reduced 17.17%
56,679 $1.85 Million
Q4 2022

Feb 14, 2023

BUY
$45.4 - $60.91 $15,753 - $21,135
347 Added 0.51%
68,424 $0
Q3 2022

Nov 04, 2022

BUY
$42.06 - $55.45 $230,909 - $304,420
5,490 Added 8.77%
68,077 $3.02 Million
Q2 2022

Aug 15, 2022

SELL
$33.54 - $52.15 $928,387 - $1.44 Million
-27,680 Reduced 30.66%
62,587 $3.05 Million
Q1 2022

May 13, 2022

BUY
$33.14 - $51.13 $2.19 Million - $3.38 Million
66,112 Added 273.7%
90,267 $4.39 Million
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $823,443 - $1.06 Million
24,155 New
24,155 $1.03 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.95B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.